The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

Investors Mutual’s Daniel Moore says there aren’t too many ASX-listed companies like blood plasma giant CSL that can compound ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks ...

Tech unicorn Atlassian reported $200 million in research and development expenditure in 2021-2022, topping the inaugural ATO ...

CSL Seqirus, a business of CSL (ASX: CSL), today announced data from a range of real-world evidence (RWE) studies, highlighting the important role influenza vaccination plays in protecting public ...

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Biofund IV raised EUR 140 million in first closing of EUR 250 million fundBiofund IV to follow Kurma’s proven investment strategy and make 16 to 20 new investmentsFirst three investments of the new ...

BMW India has confirmed that the even more hardcore version of its performance sedan, the M4, will launch in India on October ...

The S&P 500 Health Care Index, a key world benchmark for healthcare stocks, has risen about 11% this year. In comparison, the ...